A Phase 1/2 Dose-Escalation and Dose-Randomized, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults with Neovascular (Wet) Age-Related Macular Degeneration
Research Grant
Administered By
Ophthalmology
Awarded By
4D Molecular Therapeutics
Start Date
August 2, 2021
End Date
December 31, 2025
Administered By
Ophthalmology
Awarded By
4D Molecular Therapeutics
Start Date
August 2, 2021
End Date
December 31, 2025